Thymic carcinoma surgery: Difference between revisions
Jump to navigation
Jump to search
Mahshid |
Marjan Khan (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Thymic carcinoma}} | {{Thymic carcinoma}} | ||
{{CMG}}; {{AE}} {{ | {{CMG}}; {{AE}} {{Marjan}} | ||
==Overview== | ==Overview== | ||
Latest revision as of 18:36, 10 September 2019
|
Thymic Carcinoma Microchapters |
|
Diagnosis |
|---|
|
Case Studies |
|
Thymic carcinoma surgery On the Web |
|
American Roentgen Ray Society Images of Thymic carcinoma surgery |
|
Risk calculators and risk factors for Thymic carcinoma surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marjan Khan M.B.B.S.[2]
Overview
Surgery is the mainstay of treatment for thymic carcinoma.[1]
Surgery
Treatment options for thymic carcinoma include the following:[1]
- Surgery
- Radiation
- Cisplatin-based chemotherapy
- For patients with clinically resectable disease, surgical resection is often the initial therapeutic intervention.
- For clinically borderline or frankly unresectable lesions, neoadjuvant (preoperative) chemotherapy or thoracic radiation therapy, or both, is given.
- Patients presenting with locally advanced disease should be carefully evaluated and undergo multimodality therapy.
- Patients with poor performance status and high associated operative risks are generally not considered for these types of aggressive treatments.
- Patients with metastatic disease may respond to combination chemotherapy.
References
- ↑ 1.0 1.1 National Cancer Institute. General Information About Thymoma and Thymic Carcinoma Treatment. http://www.cancer.gov/types/thymoma/hp/thymoma-treatment-pdq. Accessed on 22nd December, 2015.